Skip navigation
Veuillez utiliser cette adresse pour citer ce document : http://repositorio.unb.br/handle/10482/29740
Fichier(s) constituant ce document :
Fichier TailleFormat 
ARTIGO_TreatmentPsoriasisPsoriaticArthritis.pdf174,67 kBAdobe PDFVoir/Ouvrir
Affichage complet
Élément Dublin CoreValeurLangue
dc.contributor.authorKurizky, Patricia Shupt_BR
dc.contributor.authorFerreira, Clarissa de Castropt_BR
dc.contributor.authorNogueira, Lucas Souza Carmopt_BR
dc.contributor.authorMota, Licia Maria Henrique dapt_BR
dc.date.accessioned2017-12-07T05:13:05Z-
dc.date.available2017-12-07T05:13:05Z-
dc.date.issued2015-05pt_BR
dc.identifier.citationKURIZKY, Patricia Shu et al. Treatment of psoriasis and psoriatic arthritis during pregnancy and breastfeeding. Anais Brasileiros de Dermatologia, Rio de Janeiro, v. 90, n. 3, p. 367-375, maio/jun. 2015. Disponível em: <http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962015000300367&lng=en&nrm=iso>. Acesso em: 11 abr. 2018. doi: http://dx.doi.org/10.1590/abd1806-4841.20153113.pt_BR
dc.identifier.urihttp://repositorio.unb.br/handle/10482/29740-
dc.language.isoenpt_BR
dc.publisherSociedade Brasileira de Dermatologiapt_BR
dc.rightsAcesso Abertopt_BR
dc.titleTreatment of psoriasis and psoriatic arthritis during pregnancy and breastfeedingpt_BR
dc.typeArtigopt_BR
dc.subject.keywordArtritept_BR
dc.subject.keywordLactaçãopt_BR
dc.subject.keywordGravidezpt_BR
dc.subject.keywordPsoríasept_BR
dc.rights.licenseAnais Brasileiros de Dermatologia - This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY NC 3.0). Fonte: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962015000300367&lng=en&nrm=iso. Acesso em: 11 abr. 2018.-
dc.identifier.doihttp://dx.doi.org/10.1590/abd1806-4841.20153113pt_BR
dc.description.abstract1Psoriasis is a chronic inflammatory disease that affects primarily the skin and joints, with a worldwide incidence of 2-3%. Fifty percent of patients are women, most still diagnosed during childbearing years. Currently,the estimate is that up to 107 thousand deliveries are performed annually in women with psoriasis, a percentage of them in women with moderate to severe disease. Fetal risks in pregnant women with psoriasis derive both from maternal disease and the medications used to control the illness. The purpose of this review is to study the effect of the main drugs used in the treatment of psoriasis and psoriatic arthritis during pregnancy and lactation, with particular focus on disease-modifying anti-rheumatic biological drugs, biological therapies, immunobiologics or biologics.-
dc.description.unidadeFaculdade de Medicina (FM)-
Collection(s) :Artigos publicados em periódicos e afins

Affichage abbrégé " class="statisticsLink btn btn-primary" href="/handle/10482/29740/statistics">



Tous les documents dans DSpace sont protégés par copyright, avec tous droits réservés.